SELENOI and hereditary spastic paraplegia: While SELENOI is indispensable for murine embryonic development (9), rare loss-of-function mutations in humans lead to a form of hereditary spastic paraplegia (HSP) characterized by motor impairment, microcephaly, and hypomyelination (10, 11, 12).